Gainers
- Marin Software Incorporated MRIN jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
- Miromatrix Medical Inc. MIRO shares jumped 50.1% to $13.51 after the company reported pricing of upsized initial public offering.
- Digital Brands Group, Inc. DBGI shares jumped 44.2% to $5.90 after the company reported channel expansion into Amazon Marketplace.
- Kaleido Biosciences, Inc. KLDO surged 26.4% to $8.84 on above-average volume.
- SEMrush Holdings, Inc. SEMR gained 22.3% to $24.70.
- Pieris Pharmaceuticals, Inc. PIRS surged 21.1% to $4.2899 after the company announced it received Orphan Drug Designation for cinrebafusp alfa for the treatment of gastric cancer.
- Moxian, Inc. MOXC gained 21% to $24.31 after jumping 22% on Wednesday.
- The Trade Desk, Inc. TTD surged 18.5% to $77.52 mid strength in advertising technology stocks after Google announced it is delaying the phase-out of third-party cookies on Chrome until 2023.
- India Globalization Capital, Inc. IGC rose 15.5% to $1.71. IGC said it has completed the final Cohort of its Phase 1 Clinical trial on Alzheimer’s patients.
- Arcus Biosciences, Inc. RCUS shares climbed 13.9% to $26.65 after the company disclosed data from the first interim analysis of the three-arm randomized Phase 2 ARC-7 study.
- Compugen Ltd. CGEN gained 13.8% to $8.86. recently announced updated data from its Phase 1 dose-escalation and expansion study of COM701 as a monotherapy and in a dose-escalation combination study with Bristol-Myers Squibb’s Opdivo (nivolumab).
- X Financial XYF surged 13.4% to $10.96.
- Uxin Limited UXIN rose 13.4% to $4.24 after gaining over 7% on Wednesday.
- Global-e Online Ltd. GLBE gained 12.4% to $62.00.
- Synchronoss Technologies, Inc. SNCR gained 12.3% to $2.7296.
- GTT Communications, Inc. GTT rose 11.8% to $2.77 after surging over 13% on Wednesday.
- Sprinklr, Inc. CXM shares rose 11.4% to $19.61. Sprinklr shares gained 10% on Wednesday after the company priced its IPO at $16 per share.
- DHI Group, Inc. DHX shares gained 10.6% to $3.0864 after the company announced it will add $12 million to its stock buyback, increasing the overall buyback to $20 million.
- Sierra Wireless, Inc. SWIR jumped 10.2% to $18.41. Craig-Hallum initiated coverage on Sierra Wireless with a Buy rating and announced a price target of $22.
- Lightning eMotors, Inc. ZEV surged 10.1% to $8.40. Oppenheimer initiated coverage on Lightning eMotors with an Outperform rating and announced a price target of $15.
- Property Solutions Acquisition Corp. PSAC rose 8.6% to $16.18 after climbing over 8% on Wednesday.
- Eli Lilly and Company LLY gained 7.4% to $233.13 after the company said its Donanemab received U.S. FDA's Breakthrough Therapy designation for the treatment of Alzheimer's disease.
- Aravive, Inc. ARAV gained 7% to $5.69 after the company announced initial results from the Phase 1b portion of its Phase 1b/2 study of AVB-500. The company said AVB-500 was well tolerated and they plan to expand dosing to 3 additional patients.
- Orphazyme A/S ORPH rose 7% to $7.94. Orphazyme, which recently faced a regulatory setback, said the Goldman Sachs Group briefly increased its stake in Orphazyme above 5%.
- Tower Semiconductor Ltd. TSEM rose 5.5% to $28.85 after the company, and STMicroelectronics, announced an agreement by which ST will welcome Tower to its Agrate R3 300mm fab under construction on its Agrate Brianza site in Italy.
Check out these big penny stock gainers and losers
Losers
- Portage Biotech Inc. PRTG shares tumbled 25% to $26.11 after the company reported pricing of public offering of 1 million ordinary shares at $23 per share.
- E-Home Household Service Holdings Limited EJH dipped 13.3% to $28.16.
- Rite Aid Corporation RAD fell 12.9% to $17.79 after the company reported weaker-than-expected Q1 sales.
- Aesthetic Medical International Holdings Group Limited AIH dropped 12.1% to $7.98 after the company reported Q1 earnings results.
- 4D Molecular Therapeutics, Inc. FDMT dropped 11.8% to $21.84. 4D Molecular Therapeutics an update on their rare disease ophthalmology product candidate portfolio, including initial clinical safety and tolerability data for 4D-110 for choroideremia and 4D-125 for XLRP, and termination of Roche collaboration and license agreement.
- Vinco Ventures, Inc. BBIG fell 11.1% to $4.2400 after the company announced it will spin out its Emmersive Entertainment unit.
- Adial Pharmaceuticals, Inc. ADIL shares fell 10.8% to $2.6201 after dropping 6% on Wednesday. The company recently announced plans to enter genetic testing market following allowance of U.S. patent for genetic diagnostic test.
- iSpecimen Inc. ISPC fell 8.7% to $6.02. The company recently priced its IPO at $8 per share.
- DoubleVerify Holdings, Inc. DV dropped 6.5% to $40.28.
- ReTo Eco-Solutions, Inc. RETO fell 6.1% to $1.2401. ReTo Eco-Solutions shares gained around 13% on Wednesday after the company announced a $43.7 million project to conduct annual iron ore tailings treatment.
- Talos Energy Inc. TALO shares fell 6% to $17.53 after the company reported the pricing of secondary public offering of common stock.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in